Natera, Inc. (NTRA)

USD 148.45

(0.28%)

Long Term Debt Summary of Natera, Inc.

  • Natera, Inc.'s latest annual long term debt in 2023 was 282.94 Million USD , down -21.02% from previous year.
  • Natera, Inc.'s latest quarterly long term debt in 2024 Q2 was 283.6 Million USD , up 0.12% from previous quarter.
  • Natera, Inc. reported annual long term debt of 358.23 Million USD in 2022, up 4.92% from previous year.
  • Natera, Inc. reported annual long term debt of 341.43 Million USD in 2021, up 52.6% from previous year.
  • Natera, Inc. reported quarterly long term debt of 283.27 Million USD for 2024 Q1, up 0.12% from previous quarter.
  • Natera, Inc. reported quarterly long term debt of 282.94 Million USD for 2023 FY, down -21.02% from previous quarter.

Annual Long Term Debt Chart of Natera, Inc. (2023 - 2012)

Historical Annual Long Term Debt of Natera, Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 282.94 Million USD -21.02%
2022 358.23 Million USD 4.92%
2021 341.43 Million USD 52.6%
2020 223.73 Million USD 123.84%
2019 99.95 Million USD 36.26%
2018 73.35 Million USD 0.4%
2017 73.06 Million USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 24.47 Million USD 8.95%
2013 22.46 Million USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of Natera, Inc.

Name Long Term Debt Long Term Debt Difference
Aspira Women's Health Inc. 1.43 Million USD -19686.364%
bioAffinity Technologies, Inc. 1.11 Million USD -25197.55%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -347823.122%
Standard BioTools Inc. 3.98 Million USD -7003.816%
Inotiv, Inc. 399.4 Million USD 29.159%
Prenetics Global Limited 867.21 Thousand USD -32526.857%
Neuronetics, Inc. 59.28 Million USD -377.278%
Star Equity Holdings, Inc. 1.14 Million USD -24611.354%
Castle Biosciences, Inc. 14.19 Million USD -1892.851%
Psychemedics Corporation 945 Thousand USD -29841.27%
RadNet, Inc. 812.06 Million USD 65.157%
Exact Sciences Corporation 2.47 Billion USD 88.569%
IDEXX Laboratories, Inc. 622.88 Million USD 54.575%
iSpecimen Inc. 29.13 Thousand USD -971218.229%
OpGen, Inc. 2.02 Million USD -13895.981%
Exagen Inc. 19.23 Million USD -1371.296%
Bionano Genomics, Inc. 7.17 Million USD -3843.484%
CareDx, Inc 28.27 Million USD -900.583%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD -257.376%
Guardant Health, Inc. 1.13 Billion USD 75.18%
Biodesix, Inc. 35.22 Million USD -703.251%
BioNexus Gene Lab Corp. 98.76 Thousand USD -286388.867%
Precipio, Inc. 106 Thousand USD -266829.245%
Fulgent Genetics, Inc. 10.11 Million USD -2698.388%
Sera Prognostics, Inc. 840 Thousand USD -33583.929%
23andMe Holding Co. 67.84 Million USD -317.046%
OPKO Health, Inc. 222.03 Million USD -27.433%
Personalis, Inc. 1.23 Million USD -22829.092%
Aclaris Therapeutics, Inc. 3.07 Million USD -9104.457%
Applied DNA Sciences, Inc. 739.16 Thousand USD -38179.159%
T2 Biosystems, Inc. 6.59 Million USD -4188.345%
Neogen Corporation 888.39 Million USD 68.151%
Myriad Genetics, Inc. 130.9 Million USD -116.154%
ICON Public Limited Company 3.66 Billion USD 92.281%
NeoGenomics, Inc. 606.06 Million USD 53.315%
Star Equity Holdings, Inc. 1.14 Million USD -24611.354%
MDxHealth SA 35.56 Million USD -695.594%
Prenetics Global Limited 867.21 Thousand USD -32526.857%
Illumina, Inc. 1.48 Billion USD 80.998%
DarioHealth Corp. 24.59 Million USD -1050.604%
ENDRA Life Sciences Inc. 192.06 Thousand USD -147219.616%
Medpace Holdings, Inc. 142.12 Million USD -99.086%
Mainz Biomed B.V. 2.19 Million USD -12785.214%
Trinity Biotech plc 54.65 Million USD -417.731%
Sotera Health Company 2.22 Billion USD 87.276%
bioAffinity Technologies, Inc. 1.11 Million USD -25197.55%